Livingston, NJ, United States of America

Lianhe Shu

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Hoffmann-La Roche Inc., Madrigal Pharmaceuticals, Inc.. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lianhe Shu. Retrieved from https://idiyas.com/inventor/lianhe-shu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Lianhe Shu

Introduction: Lianhe Shu, a talented inventor based in Livingston, NJ, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Lianhe Shu holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Lianhe Shu has successfully brought several inventions from concept to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Lianhe Shu has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the masses.

Conclusion: Inventor Lianhe Shu's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…